These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
75 related articles for article (PubMed ID: 8831712)
1. Immunochemical detection of carboxymethylated Apo B-100 in copper-oxidized LDL. Kato Y; Tokunaga K; Osawa T Biochem Biophys Res Commun; 1996 Sep; 226(3):923-7. PubMed ID: 8831712 [TBL] [Abstract][Full Text] [Related]
2. Characterization of a specific polyclonal antibody against 13-hydroperoxyoctadecadienoic acid-modified protein: formation of lipid hydroperoxide-modified apoB-100 in oxidized LDL. Kato Y; Makino Y; Osawa T J Lipid Res; 1997 Jul; 38(7):1334-46. PubMed ID: 9254060 [TBL] [Abstract][Full Text] [Related]
3. Detection of oxidized phospholipid-protein adducts using anti-15-hydroperoxyeicosatetraenoic acid-modified protein antibody: contribution of esterified fatty acid-protein adduct to oxidative modification of LDL. Kato Y; Osawa T Arch Biochem Biophys; 1998 Mar; 351(1):106-14. PubMed ID: 9500842 [TBL] [Abstract][Full Text] [Related]
4. Immunochemical detection of Nepsilon-(carboxyethyl)lysine using a specific antibody. Nagai R; Fujiwara Y; Mera K; Yamagata K; Sakashita N; Takeya M J Immunol Methods; 2008 Mar; 332(1-2):112-20. PubMed ID: 18242632 [TBL] [Abstract][Full Text] [Related]
5. Conventional antibody against Nepsilon-(carboxymethyl)lysine (CML) shows cross-reaction to Nepsilon-(carboxyethyl)lysine (CEL): immunochemical quantification of CML with a specific antibody. Koito W; Araki T; Horiuchi S; Nagai R J Biochem; 2004 Dec; 136(6):831-7. PubMed ID: 15671494 [TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein B carbonyl formation is enhanced by lipid peroxidation during copper-mediated oxidation of human low-density lipoproteins. Yan LJ; Lodge JK; Traber MG; Packer L Arch Biochem Biophys; 1997 Mar; 339(1):165-71. PubMed ID: 9056246 [TBL] [Abstract][Full Text] [Related]
7. Effect of desialylation on low density lipoproteins: comparative study before and after oxidative stress. Dousset N; Dousset JC; Taus M; Ferretti G; Curatola G; Soléra ML; Valdiguié P Biochem Mol Biol Int; 1994 Mar; 32(3):555-63. PubMed ID: 8032323 [TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibodies against LDL progressively oxidized by myeloperoxidase react with ApoB-100 protein moiety and human atherosclerotic lesions. Moguilevsky N; Zouaoui Boudjeltia K; Babar S; Delrée P; Legssyer I; Carpentier Y; Vanhaeverbeek M; Ducobu J Biochem Biophys Res Commun; 2004 Oct; 323(4):1223-8. PubMed ID: 15451427 [TBL] [Abstract][Full Text] [Related]
9. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin. Sakata N; Moh A; Takebayashi S Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198 [TBL] [Abstract][Full Text] [Related]
10. The mechanism of apolipoprotein B-100 thiol depletion during oxidative modification of low-density lipoprotein. Ferguson E; Singh RJ; Hogg N; Kalyanaraman B Arch Biochem Biophys; 1997 May; 341(2):287-94. PubMed ID: 9169017 [TBL] [Abstract][Full Text] [Related]
11. Sequences within apolipoprotein(a) kringle IV types 6-8 bind directly to low-density lipoprotein and mediate noncovalent association of apolipoprotein(a) with apolipoprotein B-100. Gabel BR; Koschinsky ML Biochemistry; 1998 May; 37(21):7892-8. PubMed ID: 9601051 [TBL] [Abstract][Full Text] [Related]
12. Direct evidence for apo B-100-mediated copper reduction: studies with purified apo B-100 and detection of tryptophanyl radicals. Batthyány C; Santos CX; Botti H; Cerveñansky C; Radi R; Augusto O; Rubbo H Arch Biochem Biophys; 2000 Dec; 384(2):335-40. PubMed ID: 11368321 [TBL] [Abstract][Full Text] [Related]
13. Michael addition-type 4-hydroxy-2-nonenal adducts in modified low-density lipoproteins: markers for atherosclerosis. Uchida K; Toyokuni S; Nishikawa K; Kawakishi S; Oda H; Hiai H; Stadtman ER Biochemistry; 1994 Oct; 33(41):12487-94. PubMed ID: 7918471 [TBL] [Abstract][Full Text] [Related]
14. Development of capture assays for different modifications of human low-density lipoprotein. Virella G; Derrick MB; Pate V; Chassereau C; Thorpe SR; Lopes-Virella MF Clin Diagn Lab Immunol; 2005 Jan; 12(1):68-75. PubMed ID: 15642987 [TBL] [Abstract][Full Text] [Related]
15. Effects of oxidation on the structure and stability of human low-density lipoprotein. Jayaraman S; Gantz DL; Gursky O Biochemistry; 2007 May; 46(19):5790-7. PubMed ID: 17444660 [TBL] [Abstract][Full Text] [Related]
16. Lectin-like oxidized low-density lipoprotein receptor 1 mediates matrix metalloproteinase 3 synthesis enhanced by oxidized low-density lipoprotein in rheumatoid arthritis cartilage. Kakinuma T; Yasuda T; Nakagawa T; Hiramitsu T; Akiyoshi M; Akagi M; Sawamura T; Nakamura T Arthritis Rheum; 2004 Nov; 50(11):3495-503. PubMed ID: 15529384 [TBL] [Abstract][Full Text] [Related]
17. Immunochemical characterization of purified human oxidized low-density lipoprotein antibodies. Virella G; Koskinen S; Krings G; Onorato JM; Thorpe SR; Lopes-Virella M Clin Immunol; 2000 May; 95(2):135-44. PubMed ID: 10779407 [TBL] [Abstract][Full Text] [Related]
18. Generation and initial characterization of a novel polyclonal antibody directed against homocysteine thiolactone-modified low density lipoprotein. Ferguson E; Parthasarathy S; Joseph J; Kalyanaraman B J Lipid Res; 1998 Apr; 39(4):925-33. PubMed ID: 9555955 [TBL] [Abstract][Full Text] [Related]
19. Immunoreactivity of apolipoprotein B-100 in oxidatively modified low density lipoprotein. Valentinova NV; Gu ZW; Yang M; Yanushevskaya EV; Antonov IV; Guyton JR; Smith CV; Gotto AM; Yang CY Biol Chem Hoppe Seyler; 1994 Oct; 375(10):651-8. PubMed ID: 7534086 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of leaf extract of Zanthoxylum ailanthoides on oxidation of low-density lipoprotein and accumulation of lipid in differentiated THP-1 cells. Chu CY; Lee HJ; Chu CY; Yin YF; Tseng TH Food Chem Toxicol; 2009 Jun; 47(6):1265-71. PubMed ID: 19254748 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]